These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6415352)

  • 1. Alloreactivity. I. Effects of age and thymic hormone treatment on cell-mediated immunity in C57B1/6NNia mice.
    Ghanta VK; Noble PJ; Brown ME; Cox PJ; Hiramoto NS; Hiramoto RN
    Mech Ageing Dev; 1983; 22(3-4):309-19. PubMed ID: 6415352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of thymic hormone effects on physical and immunological parameters in C57BL/6NNia mice of different ages.
    Ghanta VK; Hiramoto NS; Soong SJ; Hiramoto RN
    Ann N Y Acad Sci; 1991; 621():239-55. PubMed ID: 1859089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of thymic hormone treatment on several immune functions of nude mice.
    Ghanta VK; Hiramoto NS; Soong SJ; Hiramoto RN
    Mech Ageing Dev; 1991 May; 58(2-3):245-54. PubMed ID: 1875732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. THF, a thymic hormone, promotes interleukin-2 production in intact and thymus-deprived mice.
    Umiel T; Pecht M; Trainin N
    J Biol Response Mod; 1984 Aug; 3(4):423-34. PubMed ID: 6332883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic function in NZB mice. V. Decreased NK activity in NZB mice treated with a circulating thymic factor.
    Bardos P; Lebranchu Y; Bach MA
    Clin Immunol Immunopathol; 1982 Jun; 23(3):570-6. PubMed ID: 6889479
    [No Abstract]   [Full Text] [Related]  

  • 6. Production of anti-thymulin (FTS) monoclonal antibodies by immunization against human thymic epithelial cells.
    Berrih S; Savino W; Azoulay M; Dardenne M; Bach JF
    J Histochem Cytochem; 1984 Apr; 32(4):432-8. PubMed ID: 6200531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The decay of memory of cell-mediated cytotoxicity after primary sensitization in vivo against a tumor allograft.
    Jones KH; Adler WH
    Immunol Commun; 1978; 7(6):645-59. PubMed ID: 154468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic hormones and prostaglandins. I. Lack of stimulation of prostaglandin production by thymic hormones.
    Homo-Delarche F; Bach JF; Dardenne M
    Prostaglandins; 1989 Aug; 38(2):183-96. PubMed ID: 2788896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect.
    Igarashi T; Okada M; Kishimoto S; Yamamura Y
    Immunology; 1975 Jan; 28(1):37-47. PubMed ID: 803916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic specificity of two antibodies directed against the thymic hormone serum thymic factor (FTS).
    Fok KF; Ohga K; Incefy GS; Erickson BW
    Mol Immunol; 1982 Dec; 19(12):1667-73. PubMed ID: 6186909
    [No Abstract]   [Full Text] [Related]  

  • 12. Properties of a subpopulation of T cells bearing histamine receptors.
    Plaut M; Lichtenstein LM; Henney CS
    J Clin Invest; 1975 Apr; 55(4):856-74. PubMed ID: 164483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymic hormone containing cells. III. Evidence for a feed-back regulation of the secretion of the serum thymic factor (FTS) by thymic epithelial cells.
    Savino W; Dardenne M; Bach JF
    Clin Exp Immunol; 1983 Apr; 52(1):7-12. PubMed ID: 6683135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody against the serum thymic factor (FTS).
    Dardenne M; Pleau JM; Savino W; Bach JF
    Immunol Lett; 1982 Feb; 4(2):79-83. PubMed ID: 7037626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential resistance to growth of a tumor expressing incompatible minor alloantigens reflects regulatory influences rather than differences in anti-minor-CTL-P frequencies.
    Carayanniotis G; Halloran PF
    Cell Immunol; 1985 Mar; 91(1):100-10. PubMed ID: 2857596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of altered B7 expression in dioxin immunotoxicity: B7 transfection restores the CTL but not the autoantibody response to the P815 mastocytoma.
    Prell RA; Kerkvliet NI
    J Immunol; 1997 Mar; 158(6):2695-703. PubMed ID: 9058803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune mice develop antibodies to thymic hormone: production of anti-thymulin monoclonal autoantibodies from diabetic (db/db) and B/W mice.
    Dardenne M; Savino W; Bach JF
    J Immunol; 1984 Aug; 133(2):740-3. PubMed ID: 6539799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of facteur thymique sérique (FTS) in the thymus. I. Fixation of anti-FTS antibodies on thymic reticulo-epithelial cells.
    Monier JC; Dardenne M; Pléau JM; Schmitt D; Deschaux P; Bach JF
    Clin Exp Immunol; 1980 Dec; 42(3):470-6. PubMed ID: 7011612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociated effects of thymectomy at weaning on T-cell-mediated responses in vitro: correction by the serum thymic factor, FTS, and its analogs.
    Kaiserlian D; Dardenne M; Bach JF
    Cell Immunol; 1981 Oct; 64(1):93-101. PubMed ID: 6975177
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphocyte-mediated cytotoxicity: effects of ageing, adult thymectomy and thymic factor.
    Bach MA
    J Immunol; 1977 Aug; 119(2):641-7. PubMed ID: 142115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.